Showing results (21-30 of 190) with videos related to
Sort By:
Pageof 19
Circulation Journal : Official Journal of the Japanese Circulation Society|June 7, 2021
Optimal Management of Anticoagulation Therapy in Asian Patients With Atrial FibrillationWen-Han Cheng, Yi-Hsin Chan, Jo-Nan Liao, et al.Kardiologia Polska|February 15, 2022
Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?Jo-Nan Liao, Yi-Hsin Chan, Ling Kuo, et al.Frontiers in Cardiovascular Medicine|July 22, 2022
Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral AnticoagulantsJo-Nan Liao, Yi-Hsin Chan, Ling Kuo, et al.The Journal of Clinical Endocrinology and Metabolism|April 2, 2025
Effect of Initial eGFR and Albuminuria Changes on Clinical Outcomes in People With Diabetes Receiving SGLT2 InhibitorsBirdie Huang, Yi-Wei Kao, Kun-Chi Yen, et al.Diabetology & Metabolic Syndrome|January 18, 2023
Adverse cardiovascular, limb, and renal outcomes in patients with diabetes after peripheral artery disease revascularization treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitorsHsin-Fu Lee, Chi Chuang, Pei-Ru Li, et al.Diabetes, Obesity & Metabolism|October 21, 2024
Association of initial serum sodium change and clinical outcome in patients with diabetes receiving sodium-glucose cotransporter-2 inhibitor therapy: A multicentre database analysis in TaiwanYu-Wen Cheng, Yi-Hsin Chan, Chi Chuang, et al.Acta Cardiologica Sinica|April 29, 2016
Clinical Assessment and Implication of Left Ventricular Mechanical Dyssynchrony in Patients with Heart FailureYi-Hsin Chan, Chun-Li Wang, Chi-Tai Kuo, et al.Diabetes, Obesity & Metabolism|May 28, 2021
Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitorsYi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.Journal of the American Heart Association|April 30, 2024
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium LevelYi-Wei Kao, Tze-Fan Chao, Shao-Wei Chen, et al.Biomed Research International|January 16, 2016
Exploring the Link between the Components of Metabolic Syndrome and the Risk of DepressionFang-Yih Liaw, Tung-Wei Kao, Ju-Ting Hsueh, et al.Pageof 19